$NUS

NU SKIN ENTERPRISES INC

CIK:0001021561|SEC Filings

Consolidated Statements of Income (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Consolidated Statements of Income [Abstract]
Revenue	$ 320,112	$ 386,138	$ 640,720	$ 750,628
Cost of sales	101,787	120,405	207,932	237,934
Gross profit	218,325	265,733	432,788	512,694
Operating expenses:
Selling expenses	107,922	128,228	217,976	246,774
General and administrative expenses	90,847	106,725	189,391	219,929
Impairment expenses	78,875	0	80,714	25,114
Total operating expenses	277,644	234,953	488,081	491,817
Operating income (loss)	(59,319)	30,780	(55,293)	20,877
Interest expense	3,322	2,526	7,572	5,809
Gain on sale of business	0	0	0	176,162
Other income (expense), net	(534)	(843)	2,289	(29,218)
Income (loss) before provision for income taxes	(63,175)	27,411	(60,576)	162,012
Provision for income taxes	186,623	6,292	187,386	33,378
Net income (loss)	$ (249,798)	$ 21,119	$ (247,962)	$ 128,634
Net income (loss) per share (Note 7):
Basic (in Dollars per share)	$ (5.14)	$ 0.43	$ (5.12)	$ 2.59
Diluted (in Dollars per share)	$ (5.14)	$ 0.43	$ (5.12)	$ 2.59
Weighted-average common shares outstanding (000s):
Basic (in Shares)	48,596	49,441	48,400	49,601
Diluted (in Shares)	48,596	49,499	48,400	49,748

Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025	Dec. 31, 2025
Cash flows from operating activities:
Net income (loss)	$ (249,798)	$ 21,119	$ (247,962)	$ 128,634
Adjustments to reconcile net income to cash flows from operating activities:
Gain on sale of business	0	0	0	(176,162)
Impairment of goodwill, fixed assets and other intangibles	78,875	0	80,714	25,114
Unrealized losses on equity investments			0	28,077
Depreciation and amortization	12,658	13,052	25,000	27,258
Non-cash lease expense			12,508	13,055
Stock-based compensation			4,812	15,126
Inventory write-down			6,130	5,800
Foreign currency losses (gains)			(254)	2,441
Loss (gain) on disposal of assets			293	(72)
Deferred taxes			165,952	(6,793)
Changes in operating assets and liabilities:
Accounts receivable, net			(10,007)	(8,660)
Inventories, net			(21,260)	10,909
Prepaid expenses and other			12,728	6,251
Other assets			(4,342)	(7,356)
Accounts payable			11,733	(6,824)
Accrued expenses			(30,326)	(20,334)
Other liabilities			987	(280)
Net cash provided by operating activities			6,706	36,184
Cash flows from investing activities:
Purchases of property and equipment			(19,352)	(13,602)
Purchases of investments			(573)	0
Proceeds on investment sales			0	10,214
Proceeds from sale of business, net			0	193,725
Net cash (used in) provided by investing activities			(19,925)	190,337
Cash flows from financing activities:
Exercise of employee stock options and taxes paid related to the net shares settlement of stock awards			(4,136)	(1,142)
Payment of cash dividends			(5,786)	(5,966)
Repurchases of shares of common stock			(5,011)	(5,012)
Finance lease principal payments			(978)	(1,120)
Proceeds from debt			225,000	15,000
Payments of debt			(235,000)	(160,000)
Payment of debt issuance costs			(1,369)	0
Purchase of noncontrolling interest			(6,500)	(1,498)
Other, net				2,711
Net cash used in financing activities			(33,780)	(157,027)
Effect of exchange rate changes on cash			(1,988)	7,782
Net (decrease) increase in cash and cash equivalents			(48,987)	77,276
Cash and cash equivalents, beginning of period			238,630	186,883	$ 186,883
Cash and cash equivalents, end of period	$ 189,643	$ 264,159	$ 189,643	$ 264,159	$ 238,630

Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Jun. 30, 2026	Dec. 31, 2025
Current assets:
Cash and cash equivalents	$ 189,643	$ 238,630
Current investments	1,743	1,211
Accounts receivable, net	48,902	39,544
Inventories, net	191,497	178,643
Prepaid expenses and other	76,364	89,670
Total current assets	508,149	547,698
Property and equipment, net	379,550	377,168
Operating lease right-of-use assets	65,442	74,021
Goodwill	4,750	83,625
Other intangible assets, net	37,884	42,614
Other assets	125,755	280,187
Total assets	1,121,530	1,405,313
Current liabilities:
Accounts payable	37,711	26,183
Accrued expenses	198,636	217,551
Current portion of long-term debt	20,000	20,000
Total current liabilities	256,347	263,734
Operating lease liabilities	50,075	57,640
Long-term debt	193,664	204,187
Other liabilities	78,705	74,512
Total liabilities	578,791	600,073
Commitments and contingencies (Notes 6 and 12)
Stockholders’ equity:
Class A common stock – 500 million shares authorized, $0.001 par value, 90.6 million shares issued	91	91
Additional paid-in capital	612,412	635,994
Treasury stock, at cost – 41.9 million and 42.4 million shares	(1,558,183)	(1,575,059)
Accumulated other comprehensive loss	(118,152)	(116,105)
Retained earnings	1,606,571	1,860,319
Total stockholders' equity	542,739	805,240
Total liabilities and stockholders’ equity	$ 1,121,530	$ 1,405,313